Quantum BioPharma マネジメント
マネジメント 基準チェック /44
Quantum BioPharma's CEO is Zeeshan Saeed, appointed in Jul 2021, has a tenure of 3.33 years. total yearly compensation is $599.87K, comprised of 37.1% salary and 62.9% bonuses, including company stock and options. directly owns 6.29% of the company’s shares, worth €505.28K. The average tenure of the management team and the board of directors is 3.2 years and 3.2 years respectively.
主要情報
Zeeshan Saeed
最高経営責任者
US$599.9k
報酬総額
| CEO給与比率 | 37.1% |
| CEO在任期間 | 3.3yrs |
| CEOの所有権 | 6.3% |
| 経営陣の平均在職期間 | 3.2yrs |
| 取締役会の平均在任期間 | 3.2yrs |
経営陣の近況
Recent updates
CEO報酬分析
| 日付 | 総報酬 | 給与 | 会社業績 |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | -US$7m |
| Mar 31 2024 | n/a | n/a | -US$10m |
| Dec 31 2023 | US$600k | US$223k | -US$18m |
| Sep 30 2023 | n/a | n/a | -US$23m |
| Jun 30 2023 | n/a | n/a | -US$29m |
| Mar 31 2023 | n/a | n/a | -US$31m |
| Dec 31 2022 | US$774k | US$239k | -US$27m |
| Sep 30 2022 | n/a | n/a | -US$27m |
| Jun 30 2022 | n/a | n/a | -US$25m |
| Mar 31 2022 | n/a | n/a | -US$30m |
| Dec 31 2021 | US$1m | US$225k | -US$34m |
| Sep 30 2021 | n/a | n/a | -US$32m |
| Jun 30 2021 | n/a | n/a | -US$39m |
| Mar 31 2021 | n/a | n/a | -US$30m |
| Dec 31 2020 | US$899k | US$212k | -US$28m |
| Sep 30 2020 | n/a | n/a | -US$36m |
| Jun 30 2020 | n/a | n/a | -US$35m |
| Mar 31 2020 | n/a | n/a | -US$41m |
| Dec 31 2019 | US$2m | US$249k | -US$34m |
| Sep 30 2019 | n/a | n/a | -US$38m |
| Jun 30 2019 | n/a | n/a | -US$25m |
| Mar 31 2019 | n/a | n/a | -US$16m |
| Dec 31 2018 | US$503k | US$183k | -US$17m |
報酬と市場: Zeeshan's total compensation ($USD599.87K) is about average for companies of similar size in the German market ($USD488.36K).
報酬と収益: Zeeshan's compensation has been consistent with company performance over the past year.
CEO（最高経営責任者
Zeeshan Saeed (54 yo)
3.3yrs
在職期間
US$599,873
報酬
Mr. Zeeshan Saeed serves as Executive Co-Chairman at FSD Pharma Inc. since May 24, 2018 and serves as its President since July 27, 2021 and Chief Executive Officer since June 29, 2023. He serves as Co-Chai...
リーダーシップ・チーム
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| Founder | 3.3yrs | US$599.87k | 6.29% € 505.3k | |
| Founder & Executive Co-Chairman | 6.4yrs | US$599.87k | 5.36% € 431.1k | |
| CFO & COO | 3.3yrs | US$602.87k | 4.44% € 356.6k | |
| Controller | less than a year | US$178.21k | 0.13% € 10.8k | |
| CEO of Lucid & Director | 3.2yrs | US$521.97k | 1.17% € 94.3k | |
| Head of Finance & Mergers and Acquisitions | less than a year | データなし | データなし | |
| Corporate Secretary | no data | データなし | データなし | |
| President of FSD BioSciences | 3.7yrs | データなし | データなし | |
| Vice President of Clinical & Scientific Affairs of Lucid | no data | US$110.30k | 0% € 0 | |
| Vice President of Quality-Lucid | no data | US$144.82k | データなし |
3.2yrs
平均在職期間
48yo
平均年齢
経験豊富な経営陣: 0K91's management team is considered experienced (3.2 years average tenure).
取締役
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| Founder | 3.5yrs | US$599.87k | 6.29% € 505.3k | |
| Founder & Executive Co-Chairman | 6.4yrs | US$599.87k | 5.36% € 431.1k | |
| CEO of Lucid & Director | 2yrs | US$521.97k | 1.17% € 94.3k | |
| Member of Research & Clinical Advisory Board | 2.8yrs | データなし | データなし | |
| Member of Research & Clinical Advisory Board | 3yrs | データなし | データなし | |
| Member of Research & Clinical Advisory Board | 3.2yrs | データなし | データなし | |
| Independent Director | 1.5yrs | データなし | データなし | |
| Independent Director | 3.4yrs | US$139.37k | 0.0077% € 620.5 | |
| Member of Research & Clinical Advisory Board | 3.2yrs | データなし | データなし | |
| Member of Research & Clinical Advisory Board | 3.2yrs | データなし | データなし | |
| Member of Research & Clinical Advisory Board | 3.2yrs | データなし | データなし | |
| Member of Regulatory Advisory Board | 3yrs | データなし | データなし |
3.2yrs
平均在職期間
54yo
平均年齢
経験豊富なボード: 0K91's board of directors are considered experienced (3.2 years average tenure).